80 related articles for article (PubMed ID: 26458314)
1. Decreased expression of H3K27me3 in human ovarian carcinomas correlates with more aggressive tumor behavior and poor patient survival.
He WP; Li Q; Zhou J; H ZS; Kung HF; Guan XY; Xie D; Yang GF
Neoplasma; 2015; 62(6):932-7. PubMed ID: 26458314
[TBL] [Abstract][Full Text] [Related]
2. Intensive expression of Bmi-1 is a new independent predictor of poor outcome in patients with ovarian carcinoma.
Yang GF; He WP; Cai MY; He LR; Luo JH; Deng HX; Guan XY; Zeng MS; Zeng YX; Xie D
BMC Cancer; 2010 Apr; 10():133. PubMed ID: 20377880
[TBL] [Abstract][Full Text] [Related]
3. Expression and amplification of eIF-5A2 in human epithelial ovarian tumors and overexpression of EIF-5A2 is a new independent predictor of outcome in patients with ovarian carcinoma.
Yang GF; Xie D; Liu JH; Luo JH; Li LJ; Hua WF; Wu HM; Kung HF; Zeng YX; Guan XY
Gynecol Oncol; 2009 Feb; 112(2):314-8. PubMed ID: 19054548
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of SLC12A5 is associated with tumor progression and poor survival in ovarian carcinoma.
Yang GP; He WP; Tan JF; Yang ZX; Fan RR; Ma NF; Wang FW; Chen L; Li Y; Shen HW; You ZS; Xie D; Yang GF
Int J Gynecol Cancer; 2019 Oct; 29(8):1280-1284. PubMed ID: 31570543
[TBL] [Abstract][Full Text] [Related]
5. Decreased expression of PinX1 protein is correlated with tumor development and is a new independent poor prognostic factor in ovarian carcinoma.
Cai MY; Zhang B; He WP; Yang GF; Rao HL; Rao ZY; Wu QL; Guan XY; Kung HF; Zeng YX; Xie D
Cancer Sci; 2010 Jun; 101(6):1543-9. PubMed ID: 20367640
[TBL] [Abstract][Full Text] [Related]
6. Loss of trimethylation at lysine 27 of histone H3 is a predictor of poor outcome in breast, ovarian, and pancreatic cancers.
Wei Y; Xia W; Zhang Z; Liu J; Wang H; Adsay NV; Albarracin C; Yu D; Abbruzzese JL; Mills GB; Bast RC; Hortobagyi GN; Hung MC
Mol Carcinog; 2008 Sep; 47(9):701-6. PubMed ID: 18176935
[TBL] [Abstract][Full Text] [Related]
7. Decreased expression of Beclin 1 correlates closely with Bcl-xL expression and poor prognosis of ovarian carcinoma.
Lin HX; Qiu HJ; Zeng F; Rao HL; Yang GF; Kung HF; Zhu XF; Zeng YX; Cai MY; Xie D
PLoS One; 2013; 8(4):e60516. PubMed ID: 23573264
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of SGLT1 is correlated with tumor development and poor prognosis of ovarian carcinoma.
Lai B; Xiao Y; Pu H; Cao Q; Jing H; Liu X
Arch Gynecol Obstet; 2012 May; 285(5):1455-61. PubMed ID: 22159627
[TBL] [Abstract][Full Text] [Related]
9. Diffuse large B-cell lymphoma with histone H3 trimethylation at lysine 27: another poor prognostic phenotype independent of c-Myc/Bcl2 coexpression.
Oh EJ; Yang WI; Cheong JW; Choi SE; Yoon SO
Hum Pathol; 2014 Oct; 45(10):2043-50. PubMed ID: 25149548
[TBL] [Abstract][Full Text] [Related]
10. Protein kinase C isoform expression in ovarian carcinoma correlates with indicators of poor prognosis.
Weichert W; Gekeler V; Denkert C; Dietel M; Hauptmann S
Int J Oncol; 2003 Sep; 23(3):633-9. PubMed ID: 12888898
[TBL] [Abstract][Full Text] [Related]
11. High expression of AGBL2 is a novel prognostic factor of adverse outcome in patients with ovarian carcinoma.
He WP; Wang LL
Oncol Lett; 2019 Nov; 18(5):4900-4906. PubMed ID: 31612000
[TBL] [Abstract][Full Text] [Related]
12. CD24 is expressed in ovarian cancer and is a new independent prognostic marker of patient survival.
Kristiansen G; Denkert C; Schlüns K; Dahl E; Pilarsky C; Hauptmann S
Am J Pathol; 2002 Oct; 161(4):1215-21. PubMed ID: 12368195
[TBL] [Abstract][Full Text] [Related]
13. Elafin is downregulated during breast and ovarian tumorigenesis but its residual expression predicts recurrence.
Caruso JA; Karakas C; Zhang J; Yi M; Albarracin C; Sahin A; Bondy M; Liu J; Hunt KK; Keyomarsi K
Breast Cancer Res; 2014; 16(6):3417. PubMed ID: 25551582
[TBL] [Abstract][Full Text] [Related]
14. High expression of trimethylated histone H3 at lysine 27 predicts better prognosis in non-small cell lung cancer.
Chen X; Song N; Matsumoto K; Nanashima A; Nagayasu T; Hayashi T; Ying M; Endo D; Wu Z; Koji T
Int J Oncol; 2013 Nov; 43(5):1467-80. PubMed ID: 23969945
[TBL] [Abstract][Full Text] [Related]
15. Expression of mitogen-activated protein kinase phosphatase-1 (MKP-1) in primary human ovarian carcinoma.
Denkert C; Schmitt WD; Berger S; Reles A; Pest S; Siegert A; Lichtenegger W; Dietel M; Hauptmann S
Int J Cancer; 2002 Dec; 102(5):507-13. PubMed ID: 12432554
[TBL] [Abstract][Full Text] [Related]
16. Expression of cyclooxygenase 2 is an independent prognostic factor in human ovarian carcinoma.
Denkert C; Köbel M; Pest S; Koch I; Berger S; Schwabe M; Siegert A; Reles A; Klosterhalfen B; Hauptmann S
Am J Pathol; 2002 Mar; 160(3):893-903. PubMed ID: 11891188
[TBL] [Abstract][Full Text] [Related]
17. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
Shao HL; Shen DH; Xue WC; Li Y; Yu YZ
Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylated 4E binding protein 1: a hallmark of cell signaling that correlates with survival in ovarian cancer.
Castellvi J; Garcia A; Rojo F; Ruiz-Marcellan C; Gil A; Baselga J; Ramon y Cajal S
Cancer; 2006 Oct; 107(8):1801-11. PubMed ID: 16983702
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1.
Chambers SK; Kacinski BM; Ivins CM; Carcangiu ML
Clin Cancer Res; 1997 Jun; 3(6):999-1007. PubMed ID: 9815777
[TBL] [Abstract][Full Text] [Related]
20. Expression of carbohydrate antigens in advanced-stage ovarian carcinomas and their metastases-A clinicopathologic study.
Davidson B; Gotlieb WH; Ben-Baruch G; Kopolovic J; Goldberg I; Nesland JM; Berner A; Bjåmer A; Bryne M
Gynecol Oncol; 2000 Apr; 77(1):35-43. PubMed ID: 10739688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
